IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,427,000 | +10.1% | 77,480 | -7.9% | 0.03% | +6.7% |
| Q2 2022 | $3,114,000 | -42.3% | 84,115 | -42.2% | 0.03% | -49.2% |
| Q1 2022 | $5,394,000 | +8.5% | 145,615 | -10.9% | 0.06% | +5.4% |
| Q4 2021 | $4,973,000 | +19.5% | 163,424 | +57.8% | 0.06% | +93.1% |
| Q1 2017 | $4,162,000 | -12.6% | 103,538 | +4.0% | 0.03% | -17.1% |
| Q4 2016 | $4,761,000 | -15.7% | 99,550 | -35.4% | 0.04% | -23.9% |
| Q3 2016 | $5,648,000 | +42.9% | 154,152 | -9.1% | 0.05% | +31.4% |
| Q2 2016 | $3,952,000 | – | 169,676 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |